Dr. Ara Dikranian, M.D

NPI: 1609962026
Total Payments
$2.3M
2024 Payments
$350,278
Companies
76
Transactions
4,192
Medicare Patients
1,065
Medicare Billing
$223,919

Payment Breakdown by Category

Other$1.5M (63.3%)
Consulting$529,689 (22.7%)
Travel$213,261 (9.1%)
Food & Beverage$100,133 (4.3%)
Research$13,340 (0.6%)
Education$787.74 (0.0%)
Gifts$40.59 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1.4M 608 60.2%
Consulting Fee $529,689 173 22.7%
Travel and Lodging $213,261 838 9.1%
Food and Beverage $100,133 2,477 4.3%
Honoraria $73,502 61 3.1%
Unspecified $13,340 7 0.6%
Education $787.74 27 0.0%
Gift $40.59 1 0.0%

Payments by Type

General
$2.3M
4,185 transactions
Research
$13,340
7 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $425,478 615 $0 (2024)
PFIZER INC. $302,727 434 $0 (2024)
Mallinckrodt Hospital Products Inc. $243,854 188 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $238,566 188 $0 (2024)
GENZYME CORPORATION $175,822 218 $0 (2024)
Lilly USA, LLC $158,469 387 $0 (2024)
Amgen Inc. $108,156 270 $0 (2024)
AstraZeneca Pharmaceuticals LP $90,874 140 $0 (2024)
Mallinckrodt Enterprises LLC $86,582 197 $0 (2019)
Novartis Pharmaceuticals Corporation $78,910 164 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $350,278 527 Mallinckrodt Hospital Products Inc. ($120,549)
2023 $362,571 575 AbbVie Inc. ($88,092)
2022 $332,038 546 ABBVIE INC. ($76,176)
2021 $242,930 389 AbbVie Inc. ($69,940)
2020 $191,060 258 Boehringer Ingelheim Pharmaceuticals, Inc. ($33,295)
2019 $367,794 742 AbbVie, Inc. ($108,011)
2018 $213,778 512 PFIZER INC. ($53,369)
2017 $277,270 643 PFIZER INC. ($134,824)

All Payment Transactions

4,192 individual payment records from CMS Open Payments — Page 1 of 168

Date Company Product Nature Form Amount Type
12/23/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $29.41 General
Category: IMMUNOLOGY
12/23/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $2.21 General
Category: IMMUNOLOGY
12/20/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $15.61 General
Category: IMMUNOLOGY
12/18/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $29.96 General
Category: Immunology
12/17/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,000.00 General
Category: IMMUNOLOGY
12/17/2024 GENZYME CORPORATION KEVZARA (Biological) Food and Beverage In-kind items and services $21.91 General
Category: Rheumatology
12/17/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.64 General
Category: IMMUNOLOGY
12/13/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $19.43 General
Category: Immunology
12/13/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $1.27 General
Category: Immunology
12/11/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $22.05 General
Category: Analgesic
12/10/2024 UCB, Inc. Bimzelx (Biological) Travel and Lodging In-kind items and services $291.48 General
Category: Immunology
12/10/2024 UCB, Inc. Bimzelx (Biological) Travel and Lodging In-kind items and services $157.95 General
Category: Immunology
12/10/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Immunology
12/09/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $36.02 General
Category: IMMUNOLOGY
12/09/2024 Lilly USA, LLC TALTZ (Drug), OLUMIANT, ZEPBOUND Food and Beverage In-kind items and services $24.40 General
Category: Immunology
12/09/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.68 General
Category: Immunology
12/05/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: IMMUNOLOGY
12/05/2024 Amgen Inc. Enbrel (Biological), Otezla Food and Beverage In-kind items and services $25.89 General
Category: Inflammation
12/05/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $18.37 General
Category: Bone Health
12/04/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $111.00 General
Category: Immunology
12/03/2024 UCB, Inc. Bimzelx (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,150.00 General
Category: Immunology
11/27/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $22.68 General
Category: RESPIRATORY
11/26/2024 UCB, Inc. Bimzelx (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,000.00 General
Category: Immunology
11/26/2024 UCB, Inc. Bimzelx (Biological) Consulting Fee Cash or cash equivalent $2,300.00 General
Category: Immunology
11/26/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $6.60 General
Category: Immunology

Research Studies & Clinical Trials

Study Name Company Amount Records
TOFACITINIB CLINICAL PUBLICATION PROGRAM PFIZER INC. $9,360 5
ADALIMUMAB PFIZER CLINICAL PUBLICATION PROGRAM PFIZER INC. $3,200 1
TOFACITINIB RA CLINICAL PUBLICATION PROGRAM PFIZER INC. $780.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 276 645 $94,506 $56,390
2022 7 337 741 $105,375 $62,540
2021 3 256 653 $103,100 $66,423
2020 3 196 453 $70,350 $38,566
Total Patients
1,065
Total Services
2,492
Medicare Billing
$223,919
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 157 495 $74,250 $47,670 64.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 59 85 $10,625 $5,243 49.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 26 26 $6,500 $2,391 36.8%
20610 Aspiration and/or injection of fluid from large joint Office 2023 16 17 $2,295 $959.60 41.8%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2023 18 22 $836.00 $125.87 15.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 161 511 $76,650 $49,274 64.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 73 100 $12,500 $6,482 51.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 34 34 $8,500 $4,371 51.4%
20610 Aspiration and/or injection of fluid from large joint Office 2022 22 35 $4,725 $1,785 37.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 11 11 $1,100 $405.70 36.9%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2022 25 37 $1,406 $190.43 13.5%
J1020 Injection, methylprednisolone acetate, 20 mg Office 2022 11 13 $494.00 $31.96 6.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 180 574 $86,100 $57,744 67.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 57 57 $14,250 $7,150 50.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 19 22 $2,750 $1,529 55.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 154 409 $61,350 $33,431 54.5%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 28 28 $7,000 $3,656 52.2%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 14 16 $2,000 $1,480 74.0%

About Dr. Ara Dikranian, M.D

Dr. Ara Dikranian, M.D is a Specialist healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609962026.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ara Dikranian, M.D has received a total of $2.3M in payments from pharmaceutical and medical device companies, with $350,278 received in 2024. These payments were reported across 4,192 transactions from 76 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M).

As a Medicare-enrolled provider, Dikranian has provided services to 1,065 Medicare beneficiaries, totaling 2,492 services with total Medicare billing of $223,919. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Rheumatology
  • Location San Diego, CA
  • Active Since 10/04/2006
  • Last Updated 01/10/2023
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1609962026

Products in Payments

  • ACTHAR (Biological) $330,436
  • RINVOQ (Biological) $210,844
  • XELJANZ (Drug) $207,861
  • OFEV (Drug) $173,779
  • SAPHNELO (Biological) $91,187
  • KEVZARA (Biological) $90,649
  • TALTZ (Drug) $80,486
  • BENLYSTA (Biological) $76,458
  • Otezla (Drug) $73,108
  • COSENTYX (Biological) $69,272
  • KEVZARA (Drug) $67,503
  • SKYRIZI (Biological) $57,058
  • Rinvoq (Biological) $51,703
  • KEVZARA SARILUMAB INJECTION (Biological) $51,642
  • RAYOS (Drug) $50,714
  • INFLECTRA (Biological) $49,733
  • Humira (Biological) $40,283
  • Enbrel (Biological) $33,882
  • Actemra (Biological) $28,400
  • TAVNEOS (Drug) $26,799

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in San Diego